Back to: Home arrow Our Financial Statements arrow Consolidated Statements of Cash Flow

Consolidated Statement of Cash Flows (IFRS)

for the years ended December 31,

€ millions

2008 2007
Profit after taxes
    1,848     1,908
Adjustments to reconcile profit after taxes to net cash provided by operating activities:    
   Depreciation and amortization
539 262
   Gains/losses from at-equity investments
-1 1
   Losses on disposal of intangible assets and property, plant, and equipment
11 1
   Gains on disposal of investments
-15 -2
   Writedowns of financial assets
15 8
   Allowances for doubtful accounts
76 0
   Impacts of hedging for cash-settled share-based payment plans
40 32
   Share-based compensation including income tax benefits
19 13
   Excess tax benefit from share-based compensation
-7 0
   Deferred income taxes
-91 8
   Change in accounts receivable
-48 -521
   Change in other assets
-12 -277
   Change in accrued and other liabilities
-277 375
   Change in deferred income
61 124
Net cash provided by operating activities
2,158 1,932
     
   Acquisition of minority interests in subsidiaries
0 -48
   Business combinations, net of cash and cash equivalents acquired
-3,773 -672
   Repayment of acquirees' debt in business combinations
-450 0
   Purchase of intangible assets and property, plant, and equipment
-339 -400
   Proceeds from disposal of intangible assets and property, plant, and equipment
44 27
   Cash transferred to restricted cash
-451 -550
   Use of restricted cash
1,001 0
   Purchase of investments
-380 -768
   Sales of investments
579 1,025
   Purchase of other financial assets
-16 -20
   Sales of other financial assets
16 15
Net cash used in investing activities
-3,769 -1,391
     
   Dividends paid
-594 -556
   Purchase of treasury stock
-487 -1,005
   Proceeds from reissuance of treasury stock
85 156
   Proceeds from issuance of common stock (share-based compensation)
13 44
   Excess tax benefit from share-based compensation 7 0
   Proceeds from short-term and long-term debt
3,859 47
   Repayments of short-term and long-term debt
-1,571 -48
   Proceeds from the exercise of equity-based derivative instruments (STAR hedge)
24 75
   Purchase of equity-based derivative instruments (hedge for cash-settled
   share-based payment plans)
-55 0
Net cash provided by/used in financing activities
1,281 -1,287
     
Effect of foreign exchange rates on cash and cash equivalents
-1 -45
Net change in cash and cash equivalents
-331 -791
Cash and cash equivalents at the beginning of the period
1,608 2,399
Cash and cash equivalents at the end of the period
1,277 1,608